Filter
761
Filtered Results: 761
Text search:
drug
manufacturing
Featured
Recommendations
59
New Publications
189
Language
Document type
No document type
367
Studies & Reports
150
Guidelines
128
Manuals
44
Strategic & Response Plan
41
Fact sheets
12
Situation Updates
8
Training Material
5
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
India
36
Global
34
Kenya
32
Ghana
21
Nigeria
21
Uganda
19
Ethiopia
18
Western and Central Europe
14
South Africa
14
Sierra Leone
13
Tanzania
13
Bangladesh
13
Nepal
12
Zambia
12
Africa
10
Lesotho
9
Malawi
9
Botswana
9
Ukraine
8
Zimbabwe
8
Liberia
8
Rwanda
7
South–East Asia Region
7
Namibia
7
Myanmar / Burma
7
Philippines
6
Latin America and the Carribbean
6
Eastern Europe
5
Indonesia
5
Eswatini/ Swaziland
4
Tajikistan
3
Thailand
3
Albania
3
Haiti
3
Cambodia
3
West and Central Africa
3
East and Southern Africa
3
Russia
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
Asia
2
Germany
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Vietnam
2
Moldova
2
Sudan
2
Pakistan
2
Serbia
1
Australia
1
Benin
1
China
1
Syria
1
Burkina Faso
1
Uzbekistan
1
Mongolia
1
Guinea
1
USA
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Turkmenistan
1
Maldives
1
Mauritius
1
Brazil
1
Sri Lanka
1
South Sudan
1
Iraq
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
309
Clinical Guidelines
58
Pharmacy & Technologies
32
Public Health
27
Key Resources
20
Women & Child Health
13
Capacity Building
5
Toolboxes
Pharmacy
85
AMR
85
COVID-19
54
HIV
48
TB
38
Mental Health
34
NTDs
20
Malaria
19
Planetary Health
17
Rapid Response
14
Ebola & Marburg
14
NCDs
14
Health Financing Toolbox
12
Global Health Education
12
Specific Hazards
6
Caregiver
6
Conflict
5
Cholera
4
Natural Hazards
3
Polio
2
Refugee
1
Disability
1
Zika
1
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
The “Declaration for Accelerated Malaria Mortality Reduction in Africa” is a statement signed by African health ministers reaffirming their commitment to reducing malaria-related mortality. It pledges strengthened leadership, increased domestic financing for malaria control programs, and the imp...
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...
Issued by the Ministers of Health of High Burden High Impact (HBHI) countries in Africa. Yaounde Declaration.
Ministers committed to strengthening their health systems, stepping up domestic resources, enhancing multisectoral action and ensuring a robust accountability mechanism,” notes Dr Daniel ...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
This regional advocacy strategy on HIV and AIDS, tuberculosis (TB) and sexually transmitted infetions (STIs) is intended for use by Southern African Development Community (SADC) Member States at a national level. This is an overall advocacy strategy highlighting the most important issues relating to...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac...
The Ethiopia Multi-Sectorial Cholera Elimination Plan (2022-2028) outlines a national strategy to eliminate cholera in Ethiopia by 2028. The plan follows the Global Roadmap to End Cholera by 2030 and is based on six key pillars: Leadership & Coordination, Water, Sanitation & Hygiene (WASH), Surveill...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul...
This annual report gives an overview of WHO lesotho Country office's undertakings and achievements in the context of an extraordinary health emergency. As we walk another mile this year, may we embrace all lessonst leanred in the previous year, learn from what did not work so well and take on new op...
Antimicrobial resistance (AMR) both in human and veterinary medicine has reached alarming levels in
most parts of the world and has now been recognized as a significant emerging threat to global public
health and food security. In June 2015, the Food and Agriculture Organization of the United Nati...
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
In this edition, the Antimicrobial Resistance chapter discusses the growing, dangerous trend of antimicrobial resistance and the potential catastrophic consequences on global health.
Chapter 1 of Frontier 2017: Emerging Issues of Environmental Concern
